Earnings History Data for Pieris Pharmaceuticals, Inc. (PIRS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-05-2023	PM	0:00 AM ET (May 10)	PIRS	Pieris Pharmaceuticals, Inc.	64.04	-0.18	-0.14	-0.07	Pieris Pharmaceuticals GAAP EPS of -$0.18 misses by $0.04, revenue of $1.94M misses by $4.57M [5/10/2023 7:11 AM]	0.8441	-0.01 (-0.69%)	0.87	0.02 (2.04%)	0.72 - 2.30	208,996	1,010,000	2,690
Pieris Pharmaceuticals Q1 2023 Earnings Preview [5/9/2023 11:38 AM] Pieris Pharmaceuticals GAAP EPS of -$0.18 misses by $0.04, revenue of $1.94M misses by $4.57M [5/10/2023 7:11 AM]
29-03-2023	PM		PIRS	Pieris Pharmaceuticals, Inc.	109.38	-0.11	-0.13	-0.13	Pieris Pharmaceuticals GAAP EPS of -$0.45 beats by $0.02, revenue of $25.9M misses by $0.67M [3/29/2023 7:05 AM]	1.06	-0.42 (-28.38%)	1.19	-0.29 (-19.59%)	0.85 - 3.34	1,355,985	140,000	129,717
Pieris Pharmaceuticals Q4 2022 Earnings Preview [3/28/2023 2:23 PM] Pieris Pharmaceuticals GAAP EPS of -$0.45 beats by $0.02, revenue of $25.9M misses by $0.67M [3/29/2023 7:05 AM] Pieris stock slumps ~15% after FY22 sees fall in revenue [3/29/2023 11:04 AM]
02-11-2022	PM	0:00 AM ET (Nov 2)	PIRS	Pieris Pharmaceuticals, Inc.	82.59	-0.13	-0.16	-0.24	Pieris Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $5.37M beats by $0.86M [11/2/2022 7:11 AM]	1.01	-0.04 (-4.25%)	0.0	0.0 (0.00%)	0.96 - 4.91	181,056	110,000	0
Pieris Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $5.37M beats by $0.86M [11/2/2022 7:11 AM] Pieris Pharmaceuticals Announces Dosing of First Subject in Phase 1 Trial of Inhaled CTGF Inhibitor PRS-220 [Nov-01-22 09:15AM]
04-08-2022	PM	0:00 AM ET (Aug 4)	PIRS	Pieris Pharmaceuticals, Inc.	136.35	-0.14	-0.11	-0.25	Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03, revenue of $3.7M misses by $6.77M [8/4/2022 7:10 AM]	1.73	-0.09 (-5.22%)	1.62	-0.20 (-10.99%)	1.54 - 6.15	663,446	160,000	1,796
Pieris Pharmaceuticals Q2 2022 Earnings Preview [8/3/2022 12:35 PM] Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03, revenue of $3.7M misses by $6.77M [8/4/2022 7:10 AM] Pieris Pharma stock falls ~7% on Q2 earnings miss, discontinuation of a phase 2 study [8/4/2022 12:37 PM]
11-05-2022	PM		PIRS	Pieris Pharmaceuticals, Inc.	174.14	-0.07	-0.12	-0.07	Pieris Pharmaceuticals GAAP EPS of -$0.07 beats by $0.05, revenue of $10.99M misses by $0.31M [5/11/2022 7:10 AM]	1.81	-0.44 (-19.56%)	2.25	0.0 (0.00%)	1.72 - 6.15	1,554,413	470,000	9,282
Pieris Pharmaceuticals Q1 2022 Earnings Preview [5/10/2022 11:41 AM] Pieris Pharmaceuticals GAAP EPS of -$0.07 beats by $0.05, revenue of $10.99M misses by $0.31M [5/11/2022 7:10 AM] Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-11-22 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates [May-11-22 08:45AM]
01-03-2022	PM		PIRS	Pieris Pharmaceuticals, Inc.	222.67	-0.13	-0.30	-0.26	Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17, revenue of $31.41M beats by $5.97M [3/1/2022 7:18 AM]	3.07	-0.02 (-0.65%)	3.09	0.0 (0.00%)	1.70 - 6.15	370,566	630,000	167
Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17, revenue of $31.41M beats by $5.97M [3/1/2022 7:18 AM] Heska (HSKA) Tops Q4 Earnings and Revenue Estimates [Feb-28-22 09:25AM] Pieris Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Update [Mar-01-22 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-22 11:05AM]
02-11-2021	PM		PIRS	Pieris Pharmaceuticals, Inc.	312.87	-0.24	-0.24	-0.26	Pieris Pharmaceuticals EPS in-line, misses on revenue [11/2/2021 7:32 AM]	4.75	0.02 (0.42%)	4.75	0.0 (0.00%)	1.70 - 6.15	1,102,225	1,040,000	5,199
Pieris Pharmaceuticals EPS in-line, misses on revenue [11/2/2021 7:32 AM] Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-02-21 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Misses Revenue Estimates [Nov-02-21 09:05AM]
04-08-2021	PM		PIRS	Pieris Pharmaceuticals, Inc.	205.23	-0.25	-0.20	-0.09	Pieris Pharmaceuticals EPS beats by $0.02, beats on revenue [8/4/2021 7:19 AM]	3.65	0.01 (0.27%)	3.65	0.0 (0.00%)	1.70 - 5.09	1,903,308	1,020,000	18,968
Pieris Pharmaceuticals EPS beats by $0.02, beats on revenue [8/4/2021 7:19 AM] Pieris Pharmaceuticals Strengthens Executive R&D Leadership Team [Aug-03-21 08:00AM] Pieris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-04-21 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Misses Revenue Estimates [Aug-04-21 09:25AM]
17-05-2021	PM	0:00 AM ET (May 17)	PIRS	Pieris Pharmaceuticals, Inc.	118.38	-0.07	-0.17	-0.07	Pieris Pharmaceuticals EPS beats by $0.10, beats on revenue [5/17/2021 7:02 AM]	1.91	0.03 (1.60%)	2.00	0.12 (6.38%)	1.70 - 3.64	520,344	680,000	2,263
Pieris Pharmaceuticals EPS beats by $0.10, beats on revenue [5/17/2021 7:02 AM] Pieris Pharmaceuticals, Inc. to Host Earnings Call [May-17-21 06:15AM] Pieris Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-17-21 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Tops Revenue Estimates [May-17-21 08:50AM]
30-03-2021	PM		PIRS	Pieris Pharmaceuticals, Inc.	155.16	-0.26	-0.24	-0.11	Pieris Pharmaceuticals EPS in-line, misses on revenue [3/30/2021 7:07 AM]	2.51	0.04 (1.42%)	2.60	0.13 (5.26%)	1.94 - 3.64	517,679	700,000	18,339
Pieris Pharmaceuticals EPS in-line, misses on revenue [3/30/2021 7:07 AM] Pieris Pharmaceuticals's Earnings Outlook [Mar-29-21 10:05AM] Pieris Pharmaceuticals, Inc. to Host Earnings Call [Mar-30-21 06:15AM] Pieris Pharmaceuticals Reports Full-Year 2020 Financial Results and Provides Corporate Update [Mar-30-21 07:00AM] Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Misses Revenue Estimates [Mar-30-21 09:45AM]
04-11-2020	PM		PIRS	Pieris Pharmaceuticals, Inc.	132.57	-0.26	-0.16	-0.05	Pieris Pharmaceuticals EPS misses by $0.13, misses on revenue [11/4/2020 7:05 AM]	2.68	0.18 (7.20%)	2.48	-0.02 (-0.80%)	1.60 - 4.30	359,076	392,015	426

10-08-2020	PM		PIRS	Pieris Pharmaceuticals, Inc.	144.40	-0.09	-0.18	-0.24	Pieris Pharmaceuticals EPS beats by $0.08, beats on revenue [8/10/2020 7:05 AM]	2.79	0.22 (3.33%)	2.93	0.23 (8.37%)	1.60 - 5.97	266,583	336,048	53,133